France

Cellectis SA is a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART). The company's mission is to develop a new generation of cancer therapies based on engineered T-cells.

Innate Pharma S.A. is a biopharmaceutical company.  The Company develops first in class drugs that focus on cancer immunotherapy through the manipulation of the innate immune system.

Transgene S.A is a biotechnology company. The Company develops therapeutic vaccines and oncolytic viruses against solid tumors (lung, liver, head & neck and colorectal cancers). In addition to clinical-stage immunotherapies, Transgene S.A. develops individualized therapeutic vaccines and multi-functional oncolytic viruses.

Adocia SAS is a biotechnology company. The Company researches and develops protein delivery products for wound healing and  tissue regeneration based on growth factors. Adocia is specialized in insulin therapy and the treatment of the diabetic foot ulcer, one of the main complications of diabetes.

DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and  immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.

Genfit operates as a biopharmaceutical company. The Company focuses on the discovery and development of drug candidates and innovative diagnostic solutions. Genfit targets metabolic diseases and liver pathologies associated with them.

Nanobiotix operates as a late clinical-stage nanomedicine company. The Company offers oncology nanomedicine treatments to control and treat cancer tumors. Nanobiotix serves customers in the United States and France.

Novacyt SA operates as a specialist in cancer and infectious diseases. The Company sells diagnostic products used in oncology, microbiology, haematology, and serology testing. Novacyt serves hospitals, clinicians, health care providers, and patients worldwide.

CellSeed Inc. develops Cell-sheet regenerative medicine. The company cultures cells and builds cell-sheets to regenerate lost or functionally imparied tissues and organs. CellSeed Inc. also supports regenerative medicine industry by providing leading technology and solutions.

ISU ABXIS Co., Ltd. develops therapeutic antibodies for such as antithrombus, anti-inflammatory, anti-cancer, and rare diseases.  The Company also provides medical service such as anti-cancer drug sensitivity examination and gene examination.

Puma Biotechnology, Inc. is a development-stage biopharmaceutical company. The Company develops novel therapeutics for the treatment of various forms of cancer. Puma focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use.

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets.  Clovis target its development programs for the treatment of specific subsets of cancer populations.

Essex Bio-Technology Limited manufactures and sells biopharmaceutical products for the treatment and healing of surface wounds and organ wounds.

iNtRON Biotechnology, Inc. is a bio-venture developing bio-active agents targeting infectious organisms and driving its commercial use.

NIBEC Co Ltd. manufactures, researches, and develops medical and dental products.  The Company's products include a Bulyonghwa treatment of residual protein and teeth whitening products.

Actinogen Medical Limited operates as a biotechnology company. The Company focuses on the treatment of alzheimer's disease and mild cognitive impairment. Actinogen Medical develops a novel drug to treat the condition and other age-related neurodegenerative diseases.

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.  The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.

CrystalGenomics Incorporation develops pharmaceutical and agricultural products by structure-based drug discovery technology.  The Company also provides structural proteomic analysis services for helping drug discovery process.

OSE Immunotherapeutics SA is a biotechnology company based in France, developing immunotherapy products against invasive/metastatic late-stage cancers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00